Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Diabetes & Endocrinology

Topics

Engineering

Pathology

Medicine

Internal Medicine

Endocrinology

Show all topics

DOI

10.1016/s2213-8587(17)30309-1

Other Formats

PDF